Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 16 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 3 institutions in 2 countries.
Matteo IncertiDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy. matteo.incerti@unipr.it.ORCID 0000-0003-0687-8765
Lucia CrascìDepartment of Drug Sciences, University of Catania, V. le A. Doria 6, 95125 Catania, Italy. luciacrasci@alice.it.ORCID 0000-0002-9175-0223
Paola ViciniDepartment of Food and Drug, University of Parma, Parco Area delle Scienze 27/A, 43124 Parma, Italy. paola.vicini@unipr.it.
Esin AkiPharmaceutical Chemistry Department, Faculty of Pharmacy, Ankara University, Tandogan, Ankara 06100, Turkey. esinaki@ankara.edu.tr.ORCID 0000-0002-1560-710X
Ismail YalcinPharmaceutical Chemistry Department, Faculty of Pharmacy, Ankara University, Tandogan, Ankara 06100, Turkey. yalcin@ankara.edu.tr.
Tugba Ertan-BolelliPharmaceutical Chemistry Department, Faculty of Pharmacy, Ankara University, Tandogan, Ankara 06100, Turkey. tbolelli@ankara.edu.tr.
Venera CardileDepartment of Physiological Sciences, University of Catania, V. le A. Doria 6, 95125 Catania, Italy. cardile@unict.it.
Adriana Carol Eleonora GrazianoDepartment of Physiological Sciences, University of Catania, V. le A. Doria 6, 95125 Catania, Italy. acegraziano@tiscali.it.
Annamaria PanicoDepartment of Drug Sciences, University of Catania, V. le A. Doria 6, 95125 Catania, Italy. panico@unict.it.
University of Catania · ITAnkara University · TRUniversity of Parma · IT
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
4-Thiazolidinone Derivatives as MMP Inhibitors in Tissue Damage: Synthesis, Biological Evaluation and Docking Studies. · full record | OpenQuestion